Literature DB >> 27365296

Dopamine is Required for Activity-Dependent Amplification of Arc mRNA in Developing Postnatal Frontal Cortex.

Yizhou Ye1, Surjeet Mastwal1, Vania Yu Cao1, Ming Ren1, Qing Liu1, Wenyu Zhang1, Abdel G Elkahloun2, Kuan Hong Wang1.   

Abstract

The activity-regulated gene Arc/Arg3.1 encodes a postsynaptic protein crucially involved in glutamatergic synaptic plasticity. Genetic mutations in Arc pathway and altered Arc expression in human frontal cortex have been associated with schizophrenia. Although Arc expression has been reported to vary with age, what mechanisms regulate Arc mRNA levels in frontal cortex during postnatal development remains unclear. Using quantitative mRNA analysis of mouse frontal cortical tissues, we mapped the developmental profiles of Arc expression and found that its mRNA levels are sharply amplified near the end of the second postnatal week, when mouse pups open their eyes for the first time after birth. Surprisingly, electrical stimulation of the frontal cortex before eye-opening is not sufficient to drive the amplification of Arc mRNA. Instead, this amplification needs both electrical stimulation and dopamine D1-type receptor (D1R) activation. Furthermore, visual stimuli-driven amplification of Arc mRNA is also dependent on D1R activation and dopamine neurons located in the ventral midbrain. These results indicate that dopamine is required to drive activity-dependent amplification of Arc mRNA in the developing postnatal frontal cortex and suggest that joint electrical and dopaminergic activation is essential to establish the normal expression pattern of a schizophrenia-associated gene during frontal cortical development. Published by Oxford University Press 2016.

Entities:  

Keywords:  activity-dependent gene expression; arc; dopamine; frontal cortex; postnatal development

Mesh:

Substances:

Year:  2017        PMID: 27365296      PMCID: PMC6059174          DOI: 10.1093/cercor/bhw181

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  62 in total

Review 1.  New views of Arc, a master regulator of synaptic plasticity.

Authors:  Jason D Shepherd; Mark F Bear
Journal:  Nat Neurosci       Date:  2011-01-30       Impact factor: 24.884

2.  Disruption of prefrontal cortex large scale neuronal activity by different classes of psychotomimetic drugs.

Authors:  Jesse Wood; Yunbok Kim; Bita Moghaddam
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

3.  Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites.

Authors:  G L Lyford; K Yamagata; W E Kaufmann; C A Barnes; L K Sanders; N G Copeland; D J Gilbert; N A Jenkins; A A Lanahan; P F Worley
Journal:  Neuron       Date:  1995-02       Impact factor: 17.173

Review 4.  Early patterns of electrical activity in the developing cerebral cortex of humans and rodents.

Authors:  Rustem Khazipov; Heiko J Luhmann
Journal:  Trends Neurosci       Date:  2006-05-19       Impact factor: 13.837

Review 5.  Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates.

Authors:  B Berger; P Gaspar; C Verney
Journal:  Trends Neurosci       Date:  1991-01       Impact factor: 13.837

6.  Modeling transformations of neurodevelopmental sequences across mammalian species.

Authors:  Alan D Workman; Christine J Charvet; Barbara Clancy; Richard B Darlington; Barbara L Finlay
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

7.  Motor Learning Consolidates Arc-Expressing Neuronal Ensembles in Secondary Motor Cortex.

Authors:  Vania Yu Cao; Yizhou Ye; Surjeet Mastwal; Ming Ren; Matthew Coon; Qing Liu; Rui M Costa; Kuan Hong Wang
Journal:  Neuron       Date:  2015-06-04       Impact factor: 17.173

Review 8.  Epigenetic mechanisms of drug addiction.

Authors:  Eric J Nestler
Journal:  Neuropharmacology       Date:  2013-04-30       Impact factor: 5.250

9.  De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia.

Authors:  G Kirov; A J Pocklington; P Holmans; D Ivanov; M Ikeda; D Ruderfer; J Moran; K Chambert; D Toncheva; L Georgieva; D Grozeva; M Fjodorova; R Wollerton; E Rees; I Nikolov; L N van de Lagemaat; A Bayés; E Fernandez; P I Olason; Y Böttcher; N H Komiyama; M O Collins; J Choudhary; K Stefansson; H Stefansson; S G N Grant; S Purcell; P Sklar; M C O'Donovan; M J Owen
Journal:  Mol Psychiatry       Date:  2011-11-15       Impact factor: 15.992

10.  Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia.

Authors:  A L Guillozet-Bongaarts; T M Hyde; R A Dalley; M J Hawrylycz; A Henry; P R Hof; J Hohmann; A R Jones; C L Kuan; J Royall; E Shen; B Swanson; H Zeng; J E Kleinman
Journal:  Mol Psychiatry       Date:  2013-03-26       Impact factor: 15.992

View more
  6 in total

Review 1.  Neurobehavioral changes arising from early life dopamine signaling perturbations.

Authors:  Lorena B Areal; Randy D Blakely
Journal:  Neurochem Int       Date:  2020-04-20       Impact factor: 3.921

2.  Developmental Exposure to Psychostimulant Primes Activity-dependent Gene Induction in Frontal Cortex.

Authors:  Yizhou Ye; Qing Liu; Wenyu Zhang; Surjeet Mastwal; Kuan Hong Wang
Journal:  Dev Neurobiol       Date:  2018-12-19       Impact factor: 3.964

3.  Comparative anatomical analysis of dopamine systems in Mus musculus and Peromyscus californicus.

Authors:  Justin Buck; Matthew T C Manion; Wenyu Zhang; Erica R Glasper; Kuan Hong Wang
Journal:  Brain Struct Funct       Date:  2022-05-02       Impact factor: 3.270

4.  Genetic Feedback Regulation of Frontal Cortical Neuronal Ensembles Through Activity-Dependent Arc Expression and Dopaminergic Input.

Authors:  Surjeet Mastwal; Vania Cao; Kuan Hong Wang
Journal:  Front Neural Circuits       Date:  2016-12-06       Impact factor: 3.492

Review 5.  Milk's Role as an Epigenetic Regulator in Health and Disease.

Authors:  Bodo C Melnik; Gerd Schmitz
Journal:  Diseases       Date:  2017-03-15

Review 6.  Schizophrenia: What's Arc Got to Do with It?

Authors:  Francesca Managò; Francesco Papaleo
Journal:  Front Behav Neurosci       Date:  2017-09-20       Impact factor: 3.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.